DOPA-responsive dystonic parkinsonism--pathophysiologic considerations.
Segawa
M
M
Segawa Neurological Clinic for Children, Tokyo, Japan.
Nishiyama
N
N
Nomura
Y
Y
D000375:Aging / Q000502:physiology; D001479:Basal Ganglia / Q000473:pathology / Q000503:physiopathology; D001483:Base Sequence; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004421:Dystonia / Q000150:complications* / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D006136:GTP Cyclohydrolase / Q000172:deficiency / Q000235:genetics; D006801:Humans; D008969:Molecular Sequence Data; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology / Q000503:physiopathology
D004295:Dihydroxyphenylalanine; D006136:GTP Cyclohydrolase